GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in GeoVax Labs, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +2 vs. Q3 2021
- Shares held
- 463.6K
- +5.17K (+1.1%) vs. Q3 2021
- Total value
- $1.68M
- −$302.4K (−15.3%) vs. Q3 2021
- New holders
- 5
- 2 more added
- Sold out
- 3
- 5 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 258,766 | $937.0K | 0.00% | −397−0.2% | Reduced |
| Geode Capital Management, LLC | 52,824 | $191.0K | 0.00% | −6,273−10.6% | Reduced |
| Gsa Capital Partners LLP | 34,497 | $125.0K | 0.02% | −6,644−16.1% | Reduced |
| Dimensional Fund Advisors LP | 27,588 | $100.0K | 0.00% | +27,588 | New |
| State Street Corp | 21,700 | $79.0K | 0.00% | 00.0% | Unchanged |
| Welch & Forbes LLC | 16,994 | $62.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 15,632 | $56.0K | 0.00% | −2,302−12.8% | Reduced |
| Northern Trust Corp | 11,564 | $42.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,497 | $42.0K | 0.00% | +11,497 | New |
| Morgan Stanley | 4,980 | $18.0K | 0.00% | +3,250+187.9% | Added |
| UBS Group AG | 4,502 | $16.0K | 0.00% | +2,685+147.8% | Added |
| Wells Fargo & Company | 2,039 | $7.00K | 0.00% | −850−29.4% | Reduced |
| Stephens Consulting, LLC | 1,000 | $3.62K | 0.00% | +1,000 | New |
| Bank of America Corp | 5 | $0 | 0.00% | +5 | New |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,706−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,383−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,303−100.0% | Sold out |